Existing studies have shown that targeted inhibition of IL-6 can treat PCM in mice (97), while targeted inhibition against TNF-α alleviates the cystic neutrophil granulomatous mastitis (a type of GLM) (166, 167). This evidence concerns the gene TNF and paracoccidioidomycosis.